well said and with good figures to match
“We are monitoring our corporate costs but given the small size of our corporate team it is our
priority to fulfil our mission - to build a global business of significance for, what we believe, is the
world’s leading oral device to treat obstructive sleep apnea,� said Mr Barschow.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $163.6M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 73.5¢ | $37.09K | 50.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14661 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 101723 | 2 |
View Market Depth
| Last trade - 15.56pm 10/09/2025 (20 minute delay) ? |
| SOM (ASX) Chart |